Sales & Marketing
Sales & Marketing
We know that doctors and patients look to us to provide accurate and balanced information about our products.
We adhere to strict ethical sales and marketing practices in all our businesses, whether pharmaceuticals, vaccines or animal health.
The best way for health care companies to provide product information is to maintain informative and ethical professional relationships with health care providers. Our interactions with providers, other customers and consumers are governed by laws and regulations, and by our long-standing global Code of Conduct, “Our Values and Standards.” We enforce these external and internal standards through our Global Compliance Program.
We recognize that both our reputation for integrity and the trust that our stakeholders place in us are dependent on our ethical practices. Consequently, we want to make certain that the ways in which we market and sell our products to our customers—health care professionals, health insurers and governments—include accurate, balanced and useful information so that prescribers can make the best decisions for their patients. Our high ethical, sales and marketing standards require that scientific information is the predominant factor in prescribing decisions, reinforcing our reputation for providing high-quality products and for contributing to improvements in public health.
Our professional sales representatives and other employees inform our customers about our medicines and vaccines and their appropriate use. In some countries, where permitted by law, we may also directly inform patients and other consumers about diseases and available treatments that they may wish to discuss with their doctors.
We also sometimes market our products directly to consumers. We believe direct-to-consumer (DTC) advertising contributes to greater awareness about conditions and diseases, which can benefit public health by increasing the number of patients appropriately diagnosed and treated.
|SALES & MARKETING SUMMARY||2012||2013||2014||2015||2016|
|Number of warning letters or untitled letters from OPDP1 or APLB2 in the U.S.3||1||0||0||0||0|
|1. OPDP: Since September 2011, the Division of Drug Marketing, Advertising and Communication (DDMAC) is now the Office of Prescription Drug Promotion (OPDP).|
2. APLB: Advertising and Promotional Labeling Branch (APLB) of the FDA Center for Biologics Evaluation and Research.
3. Beginning in 2014, data now incorporates information from our Animal Health business.